KRAS A146T in NSCLC — rare; no approved targeted therapy.
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | BMA-KRAS-A146T-NSCLC |
|---|---|
| Type | Actionability |
| Status | reviewed 2026-04-27 | pending_clinical_signoff | actionability review required |
| Diseases | DIS-NSCLC |
| Sources | SRC-CIVIC SRC-NCCN-NSCLC-2025 |
Actionability Facts
| Biomarker | BIO-RAS-MUTATION |
|---|---|
| Variant | KRAS A146T |
| Disease | DIS-NSCLC |
| ESCAT tier | IV |
| Evidence summary | KRAS A146T in NSCLC — rare; no approved targeted therapy. |
Notes
ESCAT IV. FLAG: dedicated BIO-KRAS-A146T would improve granularity.
Used By
No reverse references found in the YAML corpus.